4-phenyl-3-butenoic acid has been researched along with Lung Neoplasms in 2 studies
*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, AM; Burns, TJ; Matesic, DF; May, SW; Ruch, RJ; Sidorova, TS; Tran, PL | 1 |
| Iwai, N; MartÃnez, A; Miller, MJ; Mulshine, JL; Treston, AM; Vos, M | 1 |
2 other study(ies) available for 4-phenyl-3-butenoic acid and Lung Neoplasms
| Article | Year |
|---|---|
p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acid.
Topics: Animals; Apoptosis; Cell Communication; Cell Line, Tumor; Cell Proliferation; Connexin 43; Epithelial Cells; Fatty Acids, Monounsaturated; Gap Junctions; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Liver; Lung Neoplasms; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats | 2012 |
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autocrine Communication; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cinnamates; Culture Media, Conditioned; Ditiocarb; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Growth Inhibitors; Humans; Hygromycin B; Lung Neoplasms; Mixed Function Oxygenases; Multienzyme Complexes; Oligonucleotides, Antisense; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |